DNA methyltransferase and demethylase in human prostate cancer

Molecular Carcinogenesis

Volumn 33, Issue 3, 2002, Pages 163-171

  Patra, Samir K ^a   Patra, Aditi ^a   Zhao, Hong ^a   Dahiya, Rajvir ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

DNA demethylase; DNA methyltransferase; Prostate cancer

Indexed keywords

DNA METHYLTRANSFERASE; METHYLTRANSFERASE;

ARTICLE; CARCINOGENESIS; DNA METHYLATION; ENZYME ACTIVITY; GENE INACTIVATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER;

CELL LINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OXIDOREDUCTASES, O-DEMETHYLATING; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

TRIXIS;

EID: 0036186811     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10033     Document Type: Article

References (56)

1. Alterations in DNA methylation: A fundamental aspect of neoplasia
2. Relationship between transcription and DNA methylation
3. Inhibition of DNA methylation by 5-AZA-2′ deoxycytidine suppresses the growth of human tumor cell lines
4. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells
5. DNA methylation and cancer
6. Increased DNA methyltransferase expression in leukemia
7. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer
8. Cytosine methylation and cancer
9. On the mechanism of inhibition of DNA-cytosine methyltransferase by cytosine analogs
10. Kinetic and catalytic mechanism of Hhal methyltransferase
11. Recombinant human DNA (cytosine-5) methyltransferase. II. Steady state kinetics reveal allosteric activation by methylated DNA
12. A mammalian protein with specific demethylase activity for mCpG DNA
13. DNA demethylase is a processive enzyme
14. DNA methylation is a reversible biological signal
15. DNA-methyltransferases of mammals
16. 1 to S phase transition in normal and tumor cells
17. DNA binding properties in vivo and target recognition domain sequence alignment analyses of wild-type and mutant RsrI [N6-adenine] DNA methyltransferases
18. The role of O-6 methylguanine DNA methyltransferase (MGMT) in drug resistance and strategies for its inhibition
19. 4-methylcytosine
20. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
21. Interchromosomal transfer of epigenetic states in Ascobolus: Transfer of DNA methylation is mechanistically related to homologous recombination
22. DNA hypomethylation leads to elevated mutation rates
23. Aging and DNA methylation in colorectal mucosa and cancer
24. Cancer epigenetics comes of age
25. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome
26. Chromosome instability and immonodeficiency syndrome caused by mutations in a DNA methyltransferase gene
27. Frequent methylation of estrogen receptor in prostate cancer: Correlation with tumor progression
28. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer
29. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells
30. Methylation of the neutral endopeptidase gene promoter in human prostate cancer
31. Cytdine methylation of regulatory sequences near the π-class glutathion S-transferase gene accompanies human prostatic carcinogenesis
32. Detailed methylation analysis of the glutathion S-transferase pi (GSTP1) gene in prostate cancer
33. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B
34. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
35. Methylation of the CD44 metastasis suppressor gene in human prostate cancer
36. Down regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation
37. Hypomethylation of DNA in pathological conditions of the human prostate
38. Establishment and characterization of a human primary prostate adenocarcinoma cell line (ND-1)
39. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH1
40. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
41. Microassay for DNA methyltransferase
42. Protein measurement with the folin phenol reagent
43. Preferential binding of DNA methyltransferase and increased de novo methylation of deoxyionosine containing DNA
44. Presence of a DNA demethylating activity in the nucleus of murine erythroleukemic cells
45. The essentials of DNA methylation
46. Methylation-induced repression - Belts, braces, and chromatin
47. DNA methyltransferase and histone deacetylase in prostate cancer Abstract
48. Identification and characterization of a family of mammalian methyl-CpG binding proteins
49. Feedback regulation of DNA methyltransferase gene expression by methylation
50. Evidence that protein binding specifies sites of DNA demethylation
51. DNA methyltransferases is actively retained in the cytoplasm during early development
52. Gilbert's conjecture: The search for DNA (cytosine-5) demethylase and the emergence of new functions for eukaryotic DNA (cytosine-5) methyltransferases
53. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
54. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes
55. Histone deacetylase and DNA methyltransferase in human prostate cancer
56. Hypomethylation of cytosine-5 methyltransferase in human neoplasms